CORCEPT THERAPEUTICS INC — Director's Dealing 2011

May 23, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-05-19

Reporting Person: TURNER JOSEPH L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-05-19	Stock option (right to buy)	$4.42	A	50000	Acquired	2021-05-19	Common Stock (50000)	Direct

Footnotes

F1: Shares will vest at the rate of 8.3334% per month from the vesting base date, with the final vesting of all remaining shares to occur on or before the date of Corcept's 2012 Annual Meeting.